Koers Shanghai Rightongene Biotechnology Co., Ltd.
Aandelen
688217
CNE100005212
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
25,85 CNY | +4,19% | +13,13% | -27,75% |
Omzet 2024 * | 311 mln. 42,96 mln. 40,23 mln. | Omzet 2025 * | 375 mln. 51,8 mln. 48,51 mln. | Marktkapitalisatie | 1,44 mld. 199 mln. 187 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 12 mln. 1,66 mln. 1,55 mln. | Nettowinst (verlies) 2025 * | 14 mln. 1,93 mln. 1,81 mln. | EV/omzet 2024 * | 4,64 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 3,85 x |
K/w-verhouding 2024 * |
123
x | K/w-verhouding 2025 * |
103
x | Werknemers | 501 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 54,68% |
1 dag | +4,19% | ||
1 week | +13,13% | ||
Lopende maand | -6,14% | ||
1 maand | -6,14% | ||
3 maanden | -11,59% | ||
6 maanden | -30,96% | ||
Lopend jaar | -27,75% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hui Xiong
CEO | Chief Executive Officer | 52 | 17-02-12 |
Yan Li
DFI | Director of Finance/CFO | 42 | 27-03-20 |
Jun Xiong
BRD | Director/Board Member | 48 | 01-01-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Xue Wei Yuan
BRD | Director/Board Member | 52 | 13-12-18 |
Gui Ying Zhao
BRD | Director/Board Member | 70 | 13-12-18 |
Guang Ce Jiang
BRD | Director/Board Member | 53 | 24-08-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 25,85 | +4,19% | 732 512 |
29-04-24 | 24,81 | +3,59% | 276 466 |
26-04-24 | 23,95 | +0,34% | 152 256 |
25-04-24 | 23,87 | +1,23% | 203 996 |
24-04-24 | 23,58 | +2,34% | 241 130 |
slotkoers Shanghai S.E., 30 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-27,75% | 191 mln. | |
-0,60% | 12,95 mld. | |
-9,59% | 7,84 mld. | |
+1,82% | 5,5 mld. | |
+0,02% | 4,61 mld. | |
+7,61% | 4,61 mld. | |
-47,84% | 3,4 mld. | |
+6,42% | 2,66 mld. | |
-14,59% | 2,08 mld. | |
+1,75% | 1,79 mld. |